Wall Street brokerages predict that Xylem Inc (NYSE:XYL) will post sales of $999.71 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Xylem’s earnings, with the lowest sales estimate coming in at $961.00 million and the highest estimate coming in at $1.05 billion. Xylem reported sales of $1.35 billion in the same quarter last year, which indicates a negative year over year growth rate of 25.9%. The firm is scheduled to announce its next earnings results on Thursday, August 6th.
On average, analysts expect that Xylem will report full year sales of $4.63 billion for the current year, with estimates ranging from $4.33 billion to $5.41 billion. For the next financial year, analysts anticipate that the business will post sales of $5.03 billion, with estimates ranging from $4.72 billion to $5.68 billion. Zacks’ sales averages are an average based on a survey of analysts that follow Xylem.
Xylem (NYSE:XYL) last posted its quarterly earnings results on Tuesday, May 5th. The industrial products company reported $0.23 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.37 by ($0.14). Xylem had a return on equity of 17.08% and a net margin of 7.01%. The firm had revenue of $1.12 billion for the quarter, compared to the consensus estimate of $1.15 billion. During the same period last year, the company posted $0.52 earnings per share. The business’s revenue was down 9.2% compared to the same quarter last year.
NYSE XYL traded up $1.00 on Friday, hitting $63.16. 3,189,624 shares of the stock were exchanged, compared to its average volume of 1,345,259. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.55 and a quick ratio of 1.19. The business’s fifty day moving average is $64.78 and its 200 day moving average is $73.37. Xylem has a 52 week low of $54.62 and a 52 week high of $89.34. The company has a market capitalization of $11.18 billion, a PE ratio of 31.74, a P/E/G ratio of 4.35 and a beta of 1.02.
The firm also recently declared a quarterly dividend, which was paid on Thursday, June 25th. Investors of record on Thursday, May 28th were paid a $0.26 dividend. The ex-dividend date of this dividend was Wednesday, May 27th. This represents a $1.04 annualized dividend and a dividend yield of 1.65%. Xylem’s dividend payout ratio (DPR) is presently 34.44%.
Several hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. grew its stake in Xylem by 15.9% during the first quarter. BlackRock Inc. now owns 16,296,299 shares of the industrial products company’s stock worth $1,061,377,000 after buying an additional 2,241,395 shares in the last quarter. Aristotle Capital Management LLC acquired a new stake in Xylem during the first quarter worth about $540,568,000. Parnassus Investments CA grew its stake in Xylem by 3.3% during the fourth quarter. Parnassus Investments CA now owns 6,748,915 shares of the industrial products company’s stock worth $531,747,000 after buying an additional 215,478 shares in the last quarter. Pictet Asset Management Ltd. grew its stake in Xylem by 10.1% during the fourth quarter. Pictet Asset Management Ltd. now owns 4,899,464 shares of the industrial products company’s stock worth $386,029,000 after buying an additional 449,036 shares in the last quarter. Finally, Norges Bank acquired a new stake in Xylem during the fourth quarter worth about $274,648,000. Institutional investors and hedge funds own 85.88% of the company’s stock.
Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.